This week, Marianna sits down with John Faragon to talk about the use of lenacapavir for pre-exposure prophylaxis and the findings from the PURPOSE 1 Study. Listen in to learn more about the study, how it was conducted, who it affects, and what this all means for you as an HIV care provider. 
--

Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)

--
Want to chat? Email us at [email protected] with comments or ideas for new episodes.

--
Check out our free online courses: www.necaaetc.org/rise-courses

--
Download our HIV mobile apps:

Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US

Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691